Howard Horn

Insider Reports History

Entity
Individual
Location
C/O Vir Biotechnology, Inc., 499 Illinois Street, Suite 500, San Francisco, CA
Signature
/s/ Karah Parschauer, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Howard Horn:

Insider Reports Filed by Howard Horn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
RARE Ultragenyx Pharmaceutical Inc. Oct 10, 2024 1 -$394K 4 Oct 11, 2024 Chief Financial Officer
RARE Ultragenyx Pharmaceutical Inc. Mar 1, 2024 2 $0 4 Mar 5, 2024 Chief Financial Officer
RARE Ultragenyx Pharmaceutical Inc. Oct 9, 2023 2 $0 4 Oct 10, 2023 Chief Financial Officer
RARE Ultragenyx Pharmaceutical Inc. Oct 9, 2023 0 $0 3 Oct 10, 2023 Chief Financial Officer
VIR Vir Biotechnology, Inc. Feb 23, 2023 1 -$58.4K 4 Feb 24, 2023 CFO
VIR Vir Biotechnology, Inc. Feb 17, 2023 1 -$61.3K 4 Feb 21, 2023 CFO
VIR Vir Biotechnology, Inc. Feb 22, 2022 2 $0 4 Feb 24, 2022 CFO
VIR Vir Biotechnology, Inc. Feb 17, 2022 1 -$76.4K 4 Feb 22, 2022 CFO